GNOMX Corp. Gets License for Next-Gen Epigenetic Diagnostic Tech
The Icahn School of Medicine at Mount Sinai agreed to an exclusive license option with GNOMX Corp. for the disease diagnostic tech.
Read MorePosted by Andy Lundin | Sep 18, 2023 | Diagnostic Technologies |
The Icahn School of Medicine at Mount Sinai agreed to an exclusive license option with GNOMX Corp. for the disease diagnostic tech.
Read MorePosted by Andy Lundin | Sep 18, 2023 | Womens Health |
Desired fetal diagnostic tech from the NIH includes wearable devices, in vitro diagnostic tests, imaging devices, and sensor technologies.
Read MorePosted by Andy Lundin | Sep 14, 2023 | Disease States |
AXIM’s assay uses a tiny teardrop to collect a fluid sample and can be run at a doctor’s office with results in less than 10 minutes.
Read MorePosted by Andy Lundin | Sep 13, 2023 | Womens Health |
A $3.3 million grant to develop a molecular diagnostic test for congenital syphilis has been awarded to researchers from UTHealth Houston.
Read MorePosted by Andy Lundin | Sep 13, 2023 | Clinical Chemistry Analyzers |
Carolina Liquid Chemistries Corp. now offers urine drug screens on the Diazyme DZ-Lite c270 benchtop clinical chemistry analyzer.
Read More